share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Agwunobi John O

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Agwunobi John O

bluebird bio | 4:持股變動聲明-董事 Agwunobi John O
美股SEC公告 ·  11/08 16:16

Moomoo AI 已提取核心訊息

On November 6, 2024, John O Agwunobi, associated with bluebird bio, Inc. [BLUE], completed a stock transaction involving the grant of 24,900 shares of common stock at no cost. Following this transaction, Agwunobi's direct holdings in the company increased to a total of 51,364 shares. The grant, which is a common form of compensation for executives and directors, reflects the company's commitment to aligning the interests of its leadership with those of its shareholders.
On November 6, 2024, John O Agwunobi, associated with bluebird bio, Inc. [BLUE], completed a stock transaction involving the grant of 24,900 shares of common stock at no cost. Following this transaction, Agwunobi's direct holdings in the company increased to a total of 51,364 shares. The grant, which is a common form of compensation for executives and directors, reflects the company's commitment to aligning the interests of its leadership with those of its shareholders.
2024年11月6日,與藍鳥生物公司相關的John O Agwunobi完成了一筆股票交易,涉及免費發放24,900股普通股。在此次交易之後,Agwunobi在公司的直接持股增至總共51,364股。這一發放是對公司高管和董事常見的薪酬形式,反映了公司致力於調整其領導層利益與股東利益一致的承諾。
2024年11月6日,與藍鳥生物公司相關的John O Agwunobi完成了一筆股票交易,涉及免費發放24,900股普通股。在此次交易之後,Agwunobi在公司的直接持股增至總共51,364股。這一發放是對公司高管和董事常見的薪酬形式,反映了公司致力於調整其領導層利益與股東利益一致的承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息